Cubist Systematic Strategies, LLC Atara Biotherapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.23 - $1.74 $1,836 - $13,892	-7,984 Reduced 17.97%	36,456 $18,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $327,296 - $536,208	-232,125 Reduced 83.93%	44,440 $65,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $108,322 - $219,533	72,215 Added 35.34%	276,565 $445,000
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $64,117 - $125,028	22,899 Added 12.62%	204,350 $592,000
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $444,517 - $807,929	155,971 Added 612.13%	181,451 $595,000
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $627 - $1,920	-220 Reduced 0.86%	25,480 $96,000
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $208,526 - $437,506	-44,462 Reduced 63.37%	25,700 $200,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $433,301 - $867,115	51,339 Added 272.75%	70,162 $652,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $18,771 - $25,399	1,277 Added 7.28%	18,823 $297,000
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $237,545 - $354,634	-19,812 Reduced 53.03%	17,546 $314,000
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $851,977 - $1.1 Million	-66,096 Reduced 63.89%	37,358 $581,000
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $644,252 - $953,492	46,018 Added 80.12%	103,454 $1.49 Million
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $563,967 - $1.17 Million	44,512 Added 344.41%	57,436 $1.13 Million
Q3 2020 Nov 16, 2020	BUY	$11.92 - $15.87 $77,480 - $103,155	6,500 Added 101.18%	12,924 $167,000
Q2 2020 Aug 14, 2020	SELL	$7.53 - $14.93 $244,860 - $485,493	-32,518 Reduced 83.5%	6,424 $94,000
Q1 2020 May 15, 2020	BUY	$5.69 - $17.78 $221,579 - $692,388	38,942 New	38,942 $331,000
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $683,227 - $1.05 Million	-62,739 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $208,937 - $346,317	17,368 Added 38.28%	62,739 $886,000
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $864,317 - $1.86 Million	45,371 New	45,371 $912,000
Q1 2019 May 15, 2019	SELL	$28.4 - $41.74 $37,715 - $55,430	-1,328 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$30.9 - $42.97 $41,035 - $57,064	1,328 New	1,328 $46,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account